back

Nazlee Zebardast



Country
United States
Profession
Glaucoma Specialist
Organization
Massachusetts Eye And Ear
Fields of Interest
Genetic Epidemiology


Nazlee Zebardast at WGC-2023




Thursday 29 June 2023 15:30-16:30 CEST Room E


Risk Factors

Chair(s): Francesco Oddone (Italy); Franz Grus (Germany);


Thursday 29 June 2023 15:30-16:30 CEST Expo Hall - Rapid Fire area


Rapid Fire - Session 1

Chair(s): Joe Panarelli (United States); Keith Barton (United Kingdom);

  • Validating trend-based endpoints for neuroprotection trials in glaucoma
    Giovanni Montesano (United Kingdom)
  • Machine learning derived visual field patterns are associated with glaucoma polygenic risk score in the Ocular Hypertension Treatment Study
    Nazlee Zebardast (United States)
  • Glaucoma Risk Prediction in ocular hypertension: a cohort study using electronic medical records to validate a risk predictor: GRIP study.
    Augusto Azuara-Blanco (Ireland)
  • A Deep Learning Approach to Predict Visual Field Using Retinal Nerve Fiber Layer Optical Texture Analysis Maps
    Yawen Guo (Hong Kong)
  • GlaucomAI - the first in class, intelligent decision support system for glaucomatous optic neuropathy risk diagnostics
    Robert Wasilewicz
  • Genome wide discovery via feature space mapping of deep-learning derived clinical OCT phenotypes to the UK biobank
    Nazlee Zebardast (United States)
  • Racial Differences in Prevalence and Risk Factors of Shallow Anterior Chamber Depth: The Multiethnic Ophthalmology Cohorts of California Study
    Benjamin Xu (United States)
  • Elucidating the role of primary angle closure glaucoma (PACG) susceptibility genes, EPDR1 and PLEKHA7 in PACG pathogenesis
    Anita Chan (Singapore)
  • Altered levels of soluble immune factors in tears of eyes with exfoliation glaucoma
    Zia Pradhan
  • Role of Cell Origin in Induced Pluripotent Stem Cell Differentiation for Trabecular Meshwork Restoration in Primary Open-Angle Glaucoma
    Emine Kubra Bilir (United Kingdom)
  • LOXL1 and its regulating miRNAs in Pseudoexfoliation glaucoma
    Alka Khera
  • The impact of pre-treatment Intraocular Pressure on treatment response in the LiGHT Trial: Selective Laser Trabeculoplasty compared to Medication
    Yeonjae Kim
  • The impact of pre-treatment Intraocular Pressure on treatment response in the LiGHT Trial: Selective Laser Trabeculoplasty compared to Medication
    Ahmed Fahmi (Sudan)

Friday 30 June 2023 16:45-17:45 CEST Room C


Screening and AI

Chair(s): David Friedman (United States); Siamak Yousefi (United States);

back



IMPORTANT DATES

Late registration is open

WGC-2023 has come to an end.

Thank you for attending

KEEP ME UPDATED